Phase 4 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with multiple myeloma (a type of blood cancer)
- People who are 18 years old or older
- People who have already received at least one previous cancer treatment for their multiple myeloma
- People who are starting a specific type of treatment called a BCMA-directed T-cell Engager therapy
- People whether or not they have previously received immunoglobulin (antibody) replacement therapy
Who may not be able to join:
- People who are under 18 years old
- People who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr Julie Côté, MD,FRCPC, CHU de Québec-Université Laval
Phone: 1-418-525-4444
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Severe infections
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.